Rocky Paths: Family and Society as a Double Edged Sword in the Strategies of Patients in Coping with Scleroderma: A Qualitative Descriptive Study

Leila Mamashli, Simin Jahani, Marziyeh Asadizaker2,, Nasrin Elahi, Neda Sayadi, Elham Rajaei

Abstract


Background: Family and society, as key sources of support in the patient adaptation process, can play a substantial role. However, the contribution of family and society to patients’ coping methods, encompassing both positive and negative effects, has not been sufficiently studied. This qualitative study explores the challenges of living with scleroderma, the related strategies, and the dual impact of family and society on patients’ coping strategies. Materials and Methods: This study was conducted using a qualitative approach with conventional content analysis in 2023–2024. Data were collected via semi‑structured interviews with 22 patients and eight family caregivers who were selected through purposive sampling in Ahvaz, Iran. The interviews continued until data saturation was achieved. All interviews were analyzed using Graneheim and Lundman’s approach. Results: The findings included eight categories and 22 subcategories. The categories include the following: disrupted cohesion and functional breakdown, psychological stressors, family support dynamics, disrupted support circles, dynamic social support, gaps in the society support network, comprehensive care management, and maladaptive coping mechanisms. Conclusions: This study highlights the absence of an independent scleroderma association in Iran and underscores the role of nurses, evidence‑based platforms, and media advocacy in amplifying patients’ voices. Addressing stigma, cultural misconceptions, social isolation, and financial hardship requires targeted interventions and policymaking. Particularly, nursing interventions, through educational workshops and innovative tools such as AI‑based platforms, can enhance patients’ social and informational support.

 


Keywords


Coping skills, family relations, qualitative research, scleroderma‑systemic, social environment

Full Text:

PDF

References


Zhang L, Wang H, Zhao L, Zhang J, Sun W, Chu J, et al. Unraveling the interplay between mesenchymal stem cells, gut microbiota, and systemic sclerosis: Therapeutic implications. Microbiol Spectr 2025;13:e0157624.

Good SD, Lee JY, Johnson RE, Volkmann ER. A scoping review of the epidemiology of systemic sclerosis and its organ manifestations: 2018–2024. Curr Opin Rheumatol 2025;37:103-12.

Chen A, Lax SJ, Grainge MJ, Lanyon PC, Pearce FA. Prevalence, incidence, and mortality of Raynaud’s phenomenon, Sjögren’s syndrome and scleroderma: An umbrella review of systematic reviews. Rheumatol Adv Pract 2024;8:1-14.

Mahakkanukrauh A, Ngamjarus C, Pattanittum P, Suwannaroj S, Pongkulkiat P, Onchan T, et al. Epidemiology of systemic sclerosis in the Asia-Pacific region: A systematic review and meta-analysis. Ann Med 2025;57:1-16.

Kowalska-Kępczyńska A. Systemic scleroderma—definition, clinical picture and laboratory diagnostics. J Clin Med 2022;11:1-21.

Rajaei E, Hessam A, Mowla K, Deris Zayeri Z. Statistical analysis of clinical and laboratory characteristics of systemic sclerosis. Tehran Univ Med J 2019;77:568-71.

Mohamadzadeh D, Assar S, Fatahi Z, Farsad F. Factors associated with life quality, sleep quality, and depression in systemic sclerosis patients: A cross-sectional study from Iran. Reumatismo 2025:1-12.

Allanore Y, Gharibdoost F, Jamshidi AR, Javinani A, Avouac J, Rastkar E, et al. Comparison of the clinical phenotype of systemic sclerosis patients in Iran and France in two university centers. J Scleroderma Relat Disord 2019;4:149-59.

Oksel E. Psychosocial effects of systemic sclerosis: A case report. Nurs Pract Today 2020;7:165-8.

Galetti I, Nunzio SD, Brogelli L, Mirisola V, Garbagnati C. How do systemic sclerosis manifestations influence patients’ lives? Results from a survey on patients and caregivers. Curr Med Res Opin 2021;37(suppl 2):5-15.

Milette K, Thombs BD, Maiorino K, Nielson WR, Körner A, Peláez S. Challenges and strategies for coping with scleroderma: Implications for a scleroderma-specific self-management program. Disabil Rehabil 2019;41:2506-15.

Flurey CA, Pauling JD, Saketkoo LA, Denton CP, Galdas P, Khanna D, et al. ‘I turned in my man card’: A qualitative study of the experiences, coping styles and support needs of men with systemic sclerosis. Rheumatology 2023;62:2160-7.

Mouthon L, Alami S, Boisard A-S, Chaigne B, Hachulla E, Poiraudeau S. Patients’ views and needs about systemic sclerosis and its management: A qualitative interview study. BMC Musculoskelet Disord 2017;18:1-10.

Velauthapillai A, Schepers GM, Vonk MC, van den Ende CH. Experiences of systemic sclerosis patients with home monitoring of their pulmonary function: A qualitative study. Rheumatol Adv Pract 2024;8:1-8.

Condon SE, Roesch SC, Clements PJ, Furst DE, Weisman MH, Malcarne VL. Coping profiles and health outcomes among individuals with systemic sclerosis: A latent profile analysis approach. J Scleroderma Relat Disord 2020;5:231-6.

Milette K, Thombs BD, Dewez S, Körner A, Peláez S. Scleroderma patient perspectives on social support from close social relationships. Disabil Rehabil 2020;42:1588-98.

Milette K. Supporting people with Scleroderma: Understanding different perspectives about coping and social support [dissertation]. Montreal: McGill University; 2018.

Gumuchian ST, Peláez S, Delisle VC, Carrier M-E, Jewett LR, El-Baalbaki G, et al. Understanding coping strategies among people living with scleroderma: A focus group study. Disabil Rehabil 2018;40:3012-21.

Rezaee N, Seraji M. The perceived supports for self-care in hemodialysis patients: A qualitative study. Iran J Health Educ Health Promot 2020;8:97-106.

Gumuchian ST. Exploring the experiences of living with a rare disease: Sources of distress and support group participation among patients with Scleroderma [dissertation]. Montréal, Quebec, Canada: McGill University; 2016.

Bachari S, Mandani G, Ghasemzadeh R, Shahali S. Identifying barriers to self-advocacy in women with multiple sclerosis in Iran: A qualitative study. Arch Rehabil 2021;22:378-93.

Gumuchian ST, Delisle VC, Peláez S, Malcarne VL, El‐Baalbaki G, Kwakkenbos L, et al. Reasons for not participating in scleroderma patient support groups: A cross‐sectional study. Arthritis Care Res 2018;70:275-83.

Moon KW, Hwang S-H, Yun J, Lee EB. Approval status of essential therapeutic drugs for systemic sclerosis versus that of drugs for rheumatoid arthritis. J Scleroderma Relat Disord 2024;9:23-8.

Ozen G, Pedro S, Domsic RT, Michaud K. Management practices for raynaud phenomenon in patients with systemic sclerosis: A real-world data from community-based practices in the United States. J Clin Rheumatol 2025;31:279-83.

Mirbehbahani F, Sabzi Z, Montazeri S. The relationship between insurance support and awareness, attitude, and self-care behaviors of patients with coronary artery bypass graft surgery: A cross-sectional study. J Nurs Rep Clin Pract 2025;3:351-7.

Nakayama A, Tunnicliffe DJ, Thakkar V, Singh-Grewal D, O’Neill S, Craig JC, et al. Patients’ perspectives and experiences living with systemic sclerosis: A systematic review and thematic synthesis of qualitative studies. J Rheumatol 2016;43:1363-75.

Divani S, Patel J, Stratton R. SAT0509 How money should be spent: Patients perspectives on scleroderma research funding. Ann Rheum Dis 2018;77(Suppl 2):1110.

Mamashli L, Jahani S, Asadizaker M, Elahi N, Sayadi N, Rajaei E. Multidisciplinary care is a missing link in managing people with scleroderma: A qualitative study. Nurs Health Sci 2025;27:1-17.

Poole JL, Newbill SL, Serrano J, Rosson D, Battyany J, Dyas L, et al. Engagement of patients with scleroderma to revise an internet self-management program. Patient Exp J 2019;6:75-82.

Graneheim UH, Lundman B. Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today 2004;24:105-12.

Korstjens I, Moser A. Series: Practical guidance to qualitative research. Part 4: Trustworthiness and publishing. Eur J Gen Pract 2018;24:120-4.

Greveling M, Ong VH, Denton C, Foppen W, Herman A, Jeffries-Owen N, et al. Hand function impairment in systemic sclerosis: Outcomes, mechanisms and experience (HANDSOME)–A longitudinal observational multicentre study protocol. BMJ Open 2025;15:1-7.

Vrancianu CA, Grigore C, Ancuta I, Bojinca M, Gheorghiu AM. Factors associated with employment in a cohort of patients with systemic sclerosis. J Clin Med 2025;14:1-10.

Langleben J, Dal Santo T, Golberg M, Li K, Thombs BD. Comparison of appearance dissatisfaction and appearance-related social discomfort among people with systemic sclerosis and burn injury. J Scleroderma Relat Disord 2025:23971983251326746.

Miller D, Doering J. Process of maintaining self in individuals living with systemic sclerosis: A grounded theory study of American women. West J Nurs Res 2024;46:26-35.

Farina N, Benanti G, De Luca G, Palmisano A, Peretto G, Tomassetti S, et al. The role of the multidisciplinary health care team in the management of patients with systemic sclerosis. J Multidiscip Healthc 2022;15:815-24.

Pépin M, Kwakkenbos L, Carrier M-E, Peláez S, El-Baalbaki G, Malcarne VL, et al. Reasons for attending support groups and organizational preferences: A replication study using the North American Scleroderma Support Group Survey. J Scleroderma Relat Disord 2019;4:173-86.

Atif M, Sehar A, Malik I, Mushtaq I, Ahmad N, Babar ZU. What impact does medicines shortages have on patients? A qualitative study exploring patients’ experience and views of healthcare professionals. BMC Health Serv Res 2021;21:827.

Taylor L, Hansen D, Morrisroe K, Fairley J, Calderone A, Oon S, et al. Impact of season, environmental temperature, and humidity on Raynaud phenomenon in an Australian systemic sclerosis cohort. Arthritis Care Res 2025;77:61-8.

Brijs J, Arat S, Westhovens R, Lenaerts JL, De Langhe E. Treatment adherence in systemic sclerosis: A cross‐sectional study. Musculoskelet Care 2019;17:44-53.

Miladi S, Ketata M, Makhlouf Y, Boussaa H, Abdelghani KB, Fazaa A, et al. Effect of music therapy on patients with rheumatic diseases. Explore (NY) 2024;20:380-4.

Pettersson H, Nordin A, Svenungsson E, Alexanderson H, Boström C. Experiences of physical activity and exercise in individuals with systemic sclerosis: A qualitative study. Musculoskelet Care 2020;18:150-60.

Chen YT, Murphy SL, Furst DE, Clements P, Kafaja S, Tsevat J, et al. Factors associated with life satisfaction in systemic sclerosis: Examining the moderating roles of social support and spiritual well-being. J Scleroderma Relat Disord 2023;8:107-12.

Goncalves Junior J, Siqueira LC, de Alencar Junior AE, Shinjo SK. Spirituality and religiosity in rheumatic diseases: A systematic review. J Relig Health 2025;64:3527-41.


Refbacks

  • There are currently no refbacks.